In 240 healthy premenopausal women, 6 months of (Z)-endoxifen 1 mg or 2 mg daily reduced mammographic density vs placebo (relative change −19.3% and −26.5%); 2 mg caused more vasomotor symptoms and discontinuations (11 vs 4).
RCTn = 240
Hall et al. Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial